Thomas Jefferson University

Main menu:

Technologies Available for Licensing

    Diagnostics    |    Therapeutics    |    Devices    |    Drug Discovery    |    Other

        Therapeutics

Case Number

Title

Non-Confidential Summary

Issued Patent

Lead Inventor's Website

BER_ERI.001

Use of Tempol in the Prevention of Photoaging

 

[US Patent No. 5,840,734]
     

 

CRO_CAR.002

Compositions, Kits and Methods Relating to the Human FEZ1 Gene, a Novel Tumor Suppressor Gene

NCS for Croce tumor suppressor techs (CRO_CAR.002,004,005,016)

[US Patent No. 7,141,417]
[US Patent No. 7,777,005]
   

 

CRO_CAR.004

The Human FHIT Gene

NCS for Croce tumor suppressor techs (CRO 2,4,5,16)

[United States Patent: 7220834]
[United States Patent: 6774217]
[United States Patent: 6242212]
[United States Patent: 5928884]

 

CRO_CAR.009

TCL-1 Gene And Protein And Related Methods And Compositions

NCS for Croce TCL-1 techs (CRO_CAR.009, 015)

[US Patent No. 5,985,598]
[US Patent No. 7,175,995]
[US Patent No. 7,749,715]
 

 

CRO_CAR.015

Human Chronic Lymphocytic Leukemia Modeled in Mouse by Targeted TCL1 Expression

NCS for Croce TCL-1 techs (CRO_CAR.009,015)

[US Patent No. 7,728,189]
[US Patent No. 8,168,854]
   

 

CRO_CAR.016

Novel Tumor Suppressor Gene and Compositions and Methods for Making and Using the Same

NCS for Croce tumor suppressor techs (CRO 2,4,5,16)

       

 

CRO_CAR.017

Role of microRNA Genes In Human Cancer

NCS for Croce miRNA techs (CRO 17, 25)

[US Patent No 7,723,035]
[US Patent App 12/319,331]
[US Patent App 12/727,778]
 

 

CRO_CAR.019

Involvement Of The ALL-1 Gene In A Solid Tumor1

 

[US Patent No. 5,567,586]
     

 

CRO_CAR.025

microRNA genes in cancer diagnosis and treatment

NCS for Croce miRNA techs (CRO 17, 25)

[US Patent No 7,723,030]
[US Patent App 12/751,463]
[US Patent App 12/767,279]
 

 

DIE_BER.010

Recombinant Rabies for Pre- and Post-Exposure Prophylaxis

 

       

Link

DIE_BER.012

A Method to Modulate and Enhance the Immune Response through Prime/Boost Immunization

NCS for DIE_BER.012.pdf

       

Link

DUR_MAT.005

Insulin And Insulin-Associated Peptides For Cerebral Health

NCS for DUR_MAT.005.pdf

       

 

FER_AND.002

Antibody-based Inhibitors of Excessive Deposition of Fibrotic Tissue

NCS for FER_AND.002

       

Link

HOU_YAM.005

Apoptosis of Cardiomyocytes

 

       

Link

HOU_YAM.006

Antibiotics Targeting a Growth-Dependent Bacterial Enzyme

 

       

Link

IOZ_REN.001

A Role For Decorin In Tumor Suppression

 

[US Patent No. 6,524,573]
     

Link

KAS_DAV.001

A Small Bowel Purgative for Wireless Capsule Endoscopy

NCS for KAS_DAV.001

       

 

KOP_HIL.006

Polypeptides Fused with Alfalfa Mosaic Virus or Ilarvirus Capsid Proteins

 

[US Patent No. 6,042,832]
[US Patent No. 6,448,070]
   

 

MEN_SUE.004

Method for Treatment of PCO

 

       

Link

PEZ_TIF.001H

Secretion Free Continuous Nebulizer

NCS for PEZ_TIF.001H.pdf

       

 

PRI_EDM.005

A Pocketsized Medical Auto-Injector

NCS for PRI_EDM.005.pdf

       

Link

RAB_JOS.001

Development of an Enhancer/Promoter Pair for Heart Selective Gene Expression

NCS for RAB_JOS.001

       

 

SAN_JAM.001

Peptides with High Affinity for Heparin and for Proteoglycans to be used to Promote Endothelialization of Synthetic Vascular Graft Surfaces, or to Target the Delivery of Drugs to Cell Surfaces

NCS for SAN_JAM.001, .002

[US Patent No. 6,855,801]
     

 

SAN_JAM.002

Peptides that Neutralize Heparin or Proteoglycans, or Promote Cell Adhesion or Drug Delivery

NCS for SAN_JAM.001, .002

[US Patent No. 7,259,140]
     

 

SCH_JAY.001

Treatment of Parkinson's Disease with Oligonucleotide and Triplex Technology

NCS for SCH_JAY.001, 002, 004, 008.pdf

       

Link

SCH_JAY.002

Partial Agonists at the Glycine Modulatory Site of the NMDA Receptor for Treating Cognitive Dysfunction in Parkinson's Disease

NCS for SCH_JAY.001, 002, 004, 008.pdf

       

Link

SCH_JAY.004

Method of Treating Parkinson's Disease and Composition for the Same

NCS for SCH_JAY.001, 002, 004, 008

[United States Patent: 7160913]
     

Link

SCH_JAY.008

Treatment of Parkinson's Disease and Parkinson's Disease Treatment-related Complications with RNA Inhibition Therapies

NCS for SCH_JAY.001, 002, 004, 008

       

Link

SHO_SUN.001

Pure Protein Nanoparticles for Drug Delivery

NCS for SHO_SUN.001

       

 

STR_DAV.001

SV40 Viral Vectors for Targeted Integration Into Cells

 

[US Patent No. 5,863,794]
     

Link

SUN_XIA.001

Implantable Sensor and System for Measurement and Control of Blood Constituent Levels

 

[US Patent No. 5,995,860]
[US Patent No. 6,122,536]
   

 

THO_JEF.001

Nitric Oxide Donor Compositions, Methods, Apparatus, and Kits for Alleviating Vasoconstriction and Vasospasm in a Mammal

 

[US Patent No. 6,358,536]
     

 

WIL_JOH.005

Design and Development of Masked Therapeutic Antibodies to Limit Off-Target Effects: Application to Anti-EGFR Antibodies (Also known as "EGFR-Specific ScFvs Engineered to Enable Selective Antigen Recognition Upon Proteolytic Activation")

 

       

 

ZAL_AND.002

Inhibition of Extracellular Matrix Synthesis By Antisense Compounds Directed to Nuclear Proto-Oncogenes

 

[US Patent No. 6,133,242]
     

 

Click to leave feedback
feedback